similar global cpg player growth increasingli becom
challeng organ sale growth deceler quarter price
continu deterior increasingli competit backdrop
look fair reiter sector perform
long-term top-lin algorithm lower year deliv
toward lower end top-lin guidanc colgat final
bit bullet lower evergreen target believ
give compani flex deliv earn commit
uncertain macro environ competit industri
 among competitor weigh growth colgat
organ growth deliveri averag basi bp
deceler organ growth also compar
level annual volum deterior
four straight year price past two year attribut
deceler sequenti elev level competit colgat
categori global glaxosmithklin present global
challeng local player success local emerg
market expect competit activ abat forese
new categori consider manag remain encourag
recent acquisit pca skin eltamd skin
busi offer good technolog highli recommend
profession approach consist colgat oral pet care
busi suspect colgat continu opportunist
global front colgat conserv
histor wonder current state affair across global
busi make compani bit aggress deal strategi
adjust estim rais ep estim
previous increas larg due benefit
lower effect tax rate vs previous line
manag initi guid low-double-digit ep growth call
organ growth vs guidanc low/mid-single-digit growth
price target remain unchang
valu usd unless otherwis note
price prior trade day market close estimate unless otherwis note
one best-manag mega-cap compani
entir stapl coverag colgat also deliv organ
sale growth consist ahead mega cap peer howev
expect organ sale deceler amid soften global
consum environ particularli emerg market
latin america account colgat profit
commod cost tailwind like mitig volatil
fx continu add uncertainti colgat perform
save upsid colgat announc global
growth effici program compani
expect achiev annual save
given compani execut track record
confid like abl come high end
target note program provid colgat
bp ep cushion final year
continu macro headwind latin america
colgat gener profit declin
emerg market
currenc could materi impact compani top
line profit increas competit activ
oral care colgat core market especi could
hinder organ sale growth share gain
bloomberg capit market estim upside/downside/target
price target assum likelihood
downsid scenario believ fundament expect
cl alreadi low likelihood takeout
appli weight dcf valu cl share
see colgat next-largest global cpg asset follow
unilev lead global brand cost disciplin similar
unliev believ colgat would
will seller unless premium signific
hard see given stock alreadi carri healthi
base preced acquisit scarc cpg asset
recent white wave mead johnson appli
ev/ebitda multipl cl takeout scenario valu
stock
dcf-driven downsid scenario valu cl share
downsid case assum top-lin compound-annual-growth-rate
peak profit margin
scenario colgat face stepped-up competit
competitor emerg market unabl meet cost
save expect valu colgat downsid case
assum wacc long run termin growth
rate
price target assum likelihood downsid scenario believ
fundament expect cl alreadi low likelihood takeout
appli weight dcf valu cl share see colgat next-
largest global cpg asset follow unilev lead global brand cost disciplin
similar unilev believ colgat would will seller unless
premium signific hard see given stock alreadi carri healthi
multipl believ price target support sector perform rate
risk rate price target
volatil emerg market currenc could materi impact compani
top line profit estim colgat currenc exposur select currenc
brazilian real euro mexican peso venezuelan bolivar australian
dollar british pound
volatil input cost includ supplier cost raw packag materi commod
resin tropic oil essenti oil tallow poultri corn soybean subject
wide price variat increas cost avail commod
cost energi transport necessari servic may advers affect
profit margin compani unabl pass along higher cost form price
increas otherwis achiev cost effici manufactur distribut
increas competit activ oral care colgat core market especi
could hinder organ sale growth share gain respond competit activ often
take manag time increment expens price reduct
colgate-palmol manufactur oral care person care home care product
global oral care offer includ toothpast toothbrush mouth wash dental floss
pharmaceut product primarili compani colgat brand person
care segment compani sell hand bodi soap shower gel deodor hair care
product variou brand includ palmol irish spring home care segment
compris laundri dishwash deterg household cleaner palmol
ajax brand compani also market pet food hill segment hill
scienc diet brand name compani found headquart new
ms except ep ratio
good sold
net incom attribut cl
sourc capit market estim compani document
